Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Aug 29:14:1241979.
doi: 10.3389/fphar.2023.1241979. eCollection 2023.

Extended anticoagulation for VTE: what evidence justifies it?

Affiliations

Extended anticoagulation for VTE: what evidence justifies it?

Anushka Walia et al. Front Pharmacol. .
No abstract available

Keywords: anticoagulation; clot; deep venous thromboembolism; pulmonary embolism; venous thromboembolism.

PubMed Disclaimer

Conflict of interest statement

Disclosure: VP’s Disclosures. (Research funding) Arnold Ventures (Royalties) Johns Hopkins Press, Medscape, and MedPage (Honoraria) Grand Rounds/lectures from universities, medical centers, non-profits, and professional societies. (Consulting) UnitedHealthcare and OptumRX. (Other) Plenary Session podcast has Patreon backers, YouTube, and Substack. The remaining author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

    1. Ageno W., Farjat A., Haas S., Weitz J. I., Goldhaber S. Z., Turpie A. G. G., et al. (2021). Provoked versus unprovoked venous thromboembolism: findings from GARFIELD‐VTE. Res. Pract. Thromb. Haemost. 5 (2), 326–341. 10.1002/rth2.12482 - DOI - PMC - PubMed
    1. Baglin T., Luddington R., Brown K., Baglin C. (2003). Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study. Lancet 362 (9383), 523–526. 10.1016/S0140-6736(03)14111-6 - DOI - PubMed
    1. Bounameaux H., Perrier A. (2008). Duration of anticoagulation therapy for venous thromboembolism. Hematology 2008 (1), 252–258. 10.1182/asheducation-2008.1.252 - DOI - PubMed
    1. Carrier M., Le Gal G., Wells P. S., Rodger M. A. (2010). Systematic review: case-fatality rates of recurrent venous thromboembolism and major bleeding events among patients treated for venous thromboembolism. Ann. Intern Med. 152 (9), 578–589. 10.7326/0003-4819-152-9-201005040-00008 - DOI - PubMed
    1. Chiu V., O’Connell C. (2017). Management of the incidental pulmonary embolism. Am. J. Roentgenol. 208 (3), 485–488. 10.2214/AJR.16.17201 - DOI - PubMed